Advanced search
Publication Cover
Leukemia & Lymphoma Volume 61, 2020 - Issue 13
Submit an article Journal homepage
280
Views
3
CrossRef citations to date
0
Altmetric
Letters to the Editor

Clonal evolution with acquisition of BCR-ABL1 in refractory acute myeloid leukemia post therapy with FLT3-inhibitor

Beenu Thakrala Department of Hematopathology, MD Anderson Cancer Center, Houston, TX, USACorrespondence[email protected]
,
Naval Daverb Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USA
,
Zhenya Tanga Department of Hematopathology, MD Anderson Cancer Center, Houston, TX, USA
,
Keyur P. Patela Department of Hematopathology, MD Anderson Cancer Center, Houston, TX, USA
,
Chi Young Oka Department of Hematopathology, MD Anderson Cancer Center, Houston, TX, USA
,
Sanam Loghavia Department of Hematopathology, MD Anderson Cancer Center, Houston, TX, USA
,
Joseph D. Khourya Department of Hematopathology, MD Anderson Cancer Center, Houston, TX, USA
,
Ahmad S. Alotaibib Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USA
,
Marina Konoplevab Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USA
,
Musa Yilmazb Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USA
&
L. Jeffrey Medeirosa Department of Hematopathology, MD Anderson Cancer Center, Houston, TX, USA
 show all
Pages 3243-3246 | Received 11 May 2020, Accepted 13 Jul 2020, Published online: 22 Jul 2020

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Lori A. Ramkissoon, Kaitlyn Buhlinger, Angela Nichols, Catherine C. Coombs, Matthew C. Foster, Jonathan Galeotti, Kathleen Kaiser-Rogers, Daniel R. Richardson, Nathan D. Montgomery & Joshua F. Zeidner. (2021) Clonal evolution of Philadelphia chromosome in acute myeloid leukemia after enasidenib treatment. Leukemia & Lymphoma 62:12, pages 3035-3038.
Read now

Articles from other publishers (2)

Curtis A. Lachowiez, Courtney D. DiNardo & Sanam Loghavi. (2023) Molecularly Targeted Therapy in Acute Myeloid Leukemia: Current Treatment Landscape and Mechanisms of Response and Resistance. Cancers 15:5, pages 1617.
Crossref
. (2020) Gilteritinib. Reactions Weekly 1819:1, pages 131-131.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.